Melissa M Moore1, Jane M Beith. Show Affiliations » 1. Medical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. mmm@med.usyd.edu.au
Abstract
Entities: Chemical Disease
Mesh: See more » Acute DiseaseBone Density Conservation Agents/adverse effectsBone Neoplasms/drug therapyBone Neoplasms/secondaryBreast Neoplasms/drug therapyBreast Neoplasms/pathologyCarcinoma, Ductal, Breast/drug therapyCarcinoma, Ductal, Breast/pathologyDiphosphonates/adverse effectsFemaleHumansImidazoles/adverse effectsMiddle AgedScleritis/chemically inducedUveitis, Anterior/chemically inducedZoledronic Acid
Substances: See more » Bone Density Conservation AgentsDiphosphonatesImidazolesZoledronic Acid
Year: 2008 PMID: 18341464 DOI: 10.5694/j.1326-5377.2008.tb01658.x
Source DB: PubMed Journal: Med J Aust ISSN: 0025-729X Impact factor: 7.738